OrbiMed’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $85.3M | Buy |
|
|||||
|
2023
Q2 | $33M | Hold |
|
|||||
|
2023
Q1 | $34M | Sell |
|
|||||
|
2022
Q4 | $58.2M | Sell |
|
|||||
|
2022
Q3 | $99.1K | Buy |
|
|||||
|
2022
Q2 | $73.2K | Sell |
|
|||||
|
2022
Q1 | $134M | Buy |
|
|||||
|
2021
Q4 | $209M | Buy |
|
|||||
|
2021
Q3 | $243M | Buy |
|
|||||
|
2021
Q2 | $204M | Buy |
|
|||||
|
2021
Q1 | $209M | Buy |
|
|||||
|
2020
Q4 | $252M | Sell |
|
|||||
|
2020
Q3 | $219M | Sell |
|
|||||
|
2020
Q2 | $151M | Sell |
|
|||||
|
2020
Q1 | $109M | Buy |
|
|||||
|
2019
Q4 | $173M | Buy |
|
|||||
|
2019
Q3 | $41.7M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $4.23M | Buy |
|
|||||
|
2015
Q4 | $1.02M | Sell |
|
|||||
|
2015
Q3 | $8.26M | Sell |
|
|||||
|
2015
Q2 | $21.4M | Sell |
|
|||||
|
2015
Q1 | $37.1M | Buy |
|
|||||
|
2014
Q4 | $21.6M | Hold |
|
|||||
|
2014
Q3 | $20.4M | Sell |
|
|||||
|
2014
Q2 | $23.4M | Sell |
|
|||||
|
2014
Q1 | $24.3M | Hold |
|
|||||
|
2013
Q4 | $21.2M | Buy |
|
|||||
|
2013
Q3 | $17.4M | Buy |
|